CLEVELAND, April 11, 2024 (Globe Newswire) — Sotera Health Company (Nasdaq: SHC), the world's leading provider of mission-critical end-to-end sterilization solutions and laboratory and advisory services for the healthcare industry. today plans to announce its financial results for the first quarter ended March 31, 2024, before the market opens on Thursday, May 2, 2024. Following the announcement, management will hold a conference call at 9:00 a.m. ET to discuss the Company's operations. Highlights and financial results.
To join the live call, dial 1-844-481-2916 if dialing in from the United States or 1-412-317-0709 if dialing in from anywhere else. A live webcast of the conference call can be accessed at: Link Or contact us through the Investor Relations section of our website. Presentations and Events | Sotera Health, along with accompanying materials. A replay of the webcast will be available for viewing on the evening of May 2nd.
You can always find up-to-date information on recent developments in investor-related matters in the Investor Information section of our website. Information for investors | Sotera Health. The latest information on developments related to ethylene oxide can be found below. Ethylene oxide | Sotera Health.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, clinical testing and advisory services for the healthcare industry. Sotera Health goes to market through his three businesses – Sterigenics®Nordion® and the Nelson Institute®. Sotera Health is committed to our mission of protecting the world's health.®.
contact address
Jason Peterson
Sotera Health Vice President and Treasurer
IR@soterahealth.com
Christine Gibbs
Sotera Health Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
